リチウムとレボドーパはパーキンソン病の治療に役立ちます.

[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)].

Annales de cardiologie et d'angeiologie·2017

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.

Journal of thrombosis and haemostasis : JTH·2013

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

Archives of cardiovascular diseases·2012

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

Diabetes & metabolism·2012

Oral antiplatelet agents in ACS: from pharmacology to clinical differences.

Fundamental & clinical pharmacology·2010

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

Clinical pharmacology and therapeutics·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Journal of nephrology·2026

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

International journal of clinical pharmacy·2026

Pharmacists in OPAT: a systematic review and meta-analysis.

The Journal of antimicrobial chemotherapy·2026

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Healthcare (Basel, Switzerland)·2026

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

PloS one·2026

関連する実験動画

リチウムとレボドーパはパーキンソン病の治療に役立ちます.

関連する概念動画

[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)].

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

Oral antiplatelet agents in ACS: from pharmacology to clinical differences.

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

Pharmacists in OPAT: a systematic review and meta-analysis.

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

関連する実験動画

リチウムとレボドーパはパーキンソン病の治療に役立ちます.

関連する概念動画

関連記事